Status:
COMPLETED
Exploring the Role of Serum Methylmalonic Acid (MMA) in Breast Cancer
Lead Sponsor:
KU Leuven
Conditions:
Breast Cancer
Eligibility:
FEMALE
18+ years
Brief Summary
This project aims to investigate the role of MMA in breast cancer. To this end, we will measure MMA on serum samples collected at the time of breast cancer diagnosis, to investigate the role of MMA in...
Detailed Description
This project aims to investigate the role of MMA in breast cancer. To this end, we will measure MMA on serum samples collected at the time of breast cancer diagnosis, to investigate the role of MMA in...
Eligibility Criteria
Inclusion
- Female patients older than 18 years at diagnosis.
- First diagnosis of invasive breast cancer.
- All pathological parameters are available to identify histological subtype according to standard procedures.
- Availability of frozen serum samples at diagnosis.
- Voluntarily signed Informed Consent obtained before blood drawing for biobanking was performed.
Exclusion
- Pregnant at diagnosis.
- stage 0 disease (in situ).
- Bilateral BC at diagnosis or multifocal unilateral BC with different histology.
- Other subtypes than Invasive ductal carcinoma.
- Prior breast cancer.
Key Trial Info
Start Date :
January 22 2021
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
June 24 2022
Estimated Enrollment :
300 Patients enrolled
Trial Details
Trial ID
NCT05352737
Start Date
January 22 2021
End Date
June 24 2022
Last Update
July 22 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Lab of Experimental Oncology
Leuven, State Or Province:, Belgium, 3000